Scarica l'app Stockscreener
0.888
1.11%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
SELLAS Life Sciences Group, Inc. Triggers Interim Analysis in Phase 3 Regal Trial of GPS in Acute Myeloid Leukemia - Marketscreener.com
SELLAS Life Sciences Advances Phase 3 AML Trial - TipRanks
SELLAS triggers interim analysis in AML trial - Investing.com
SELLAS triggers interim analysis in AML trial By Investing.com - Investing.com Canada
SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia - GlobeNewswire
SELLAS Life Sciences Hits Major Milestone in Phase 3 AML Cancer Treatment Trial - StockTitan
SELLAS reports promising AML drug trial results By Investing.com - Investing.com Canada
SELLAS reports promising AML drug trial results - Investing.com India
SELLAS Announces Positive Overall Survival and Overall Response Rate Data from the Phase 2 Trial of SLS009 in r/r AML - The Manila Times
SELLAS Announces Positive Overall Survival and Overall - GlobeNewswire
SELLAS' SLS009 Triples Survival Time in Phase 2 AML Trial, Shows Breakthrough Response Rates - StockTitan
Anson Funds Management LP Purchases Shares of 793,835 SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) - MarketBeat
SELLAS announces data indicating key predictor of response to SLS009 in solid cancers - Yahoo Finance
SELLAS Announces Positive Data from Preclinical Studies - GlobeNewswire
SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor - The Bakersfield Californian
SELLAS Life Sciences' SLS009 Shows 67% Efficacy in ASXL1-Mutated Cancer Study | SLS Stock News - StockTitan
Here's Why SELLAS Life Sciences Group (NASDAQ:SLS) Must Use Its Cash Wisely - Simply Wall St
We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate - Yahoo Finance
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
SELLAS Reports 31% Response Rate in AML Trial, Narrows Q3 Loss to $7.1M | SLS Stock News - StockTitan
Highbridge Capital Management's Strategic Acquisition of SELLAS Life Sciences Shares - GuruFocus.com
SELLAS Life Sciences to Present at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition 2024 - GlobeNewswire
Northrop Grumman Corp (NOC-N) QuotePress Release - The Globe and Mail
SELLAS' Cancer Drug Shows 50% Response Rate in Leukemia Trial, Doubles Survival Time | SLS Stock News - StockTitan
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Decrease in Short Interest - MarketBeat
FDA grants rare pediatric disease designation to SELLAS cancer drug By Investing.com - Investing.com Australia
SELLAS Announces U.S. FDA Rare Pediatric Disease - GlobeNewswire
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S - The Bakersfield Californian
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia - StockTitan
SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
Trading Day Triumph: SELLAS Life Sciences Group Inc (SLS) Ends at 1.19, a -2.46 Surge/Plunge - The Dwinnex
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
SELLAS extends Times Square lease through 2026 - Investing.com
SELLAS extends Times Square lease through 2026 By Investing.com - Investing.com Australia
What is SELLAS Life Sciences Group Inc (SLS) Stock Return on Shareholders’ Capital? - SETE News
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 0.8% - MarketBeat
Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech
Biotech Soars On Material Transfer Agreement - Invezz
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Lombard Odier Asset Management Europe Ltd Sells 15,000 Shares of StoneCo Ltd. (NASDAQ:STNE) - Defense World
Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug - XM
Steniel Manufacturing board clears share offering to raise up to P315m - manilastandard.net
How did SELLAS Life Sciences Group Inc (SLS) fare last session? - US Post News
SLM price target lowered to $26 from $29 at Wedbush - TipRanks
Setna iO announces new UK headquarters - AviTrader
Inspire Investing LLC Boosts Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Australia's Stelar Metals rises on copper, silver find - XM
Quarterly Metrics: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS) - The Dwinnex
Investor’s Delight: ENDRA Life Sciences Inc (NDRA) Closes Weak at 0.20, Down -6.77 - The Dwinnex
Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Major Stake Changes in Senco Gold: Oman-India Fund Sells, ICICI Prudential Buys - Devdiscourse
Plenham Limited statement: Jason Moseley - Bodyshop Magazine
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):